Latest Market Research Report 2025

  The global genomics market was valued at   USD 32.65 billion   in 2023 and is projected to grow at a   CAGR of 16.5%   from 2024 to 2030. This robust growth is largely attributed to the increasing demand for   gene therapies,   personalized medicine, and   drug discovery, as well as the rising incidence of   cancer   and the expanding market for   consumer genomics. Over the past few years, advancements in genomic technologies and their applications across various fields of healthcare have catalyzed the widespread adoption of genomics in both clinical and consumer settings. Additionally, the rising number of   joint ventures and partnerships   among industry players is expected to foster further growth. For example, in   June 2022,   Illumina, Inc.   and   Allegheny Health Network   entered a collaboration aimed at evaluating the impact of   Comprehensive Genomic Profiling (CGP)   on im...

The global genomics market was valued at approximately USD 32.65 billion in 2023 and is projected to experience robust growth, with an anticipated compound annual growth rate (CAGR) of 16.5% from 2024 to 2030. This expansion is primarily driven by several key factors, including an increasing demand for gene therapy and personalized medicine, advancements in drug discovery, and a rising incidence of cancer. Additionally, there has been a significant uptick in consumer interest in genomics, further propelling market growth. The landscape of the genomics market is also being shaped by an increasing number of joint ventures and partnerships among major players, which are expected to enhance collaborative efforts and innovation within the sector. For instance, in June 2022, Illumina, Inc. partnered with Allegheny Health Network to effectively assess the impact of their Comprehensive Genomic Profiling (CGP) on patient care, highlighting the importance of collaboration in advancing genomic ap...

  The global genomics market was valued at USD 32.65 billion in 2023, and it is expected to grow at a compound annual growth rate (CAGR) of 16.5% from 2024 to 2030. Several key factors are driving this growth. These include the increasing demand for gene therapy, personalized medicine, and drug discovery, as well as the rising incidence of cancer. Additionally, the market has seen a surge in the demand for consumer genomics services in recent years. Collaborations and partnerships between market players are also expected to play a significant role in the expansion of the genomics market. For example, in June 2022, Illumina, Inc. entered into a partnership with Allegheny Health Network to evaluate the impact of in-house Comprehensive Genomic Profiling (CGP) on improving patient care. The launch of numerous genomic surveillance programs across various countries has played a critical role in responding to the COVID-19 pandemic and developing effective preventive measures. One notable ...

  Genomics Industry Overview The global genomics market size was valued at USD 20.1 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 15.35% from 2021 to 2028. The scientific community has tried to address genetic susceptibility and severity to SARS-CoV-2 infection by combining research efforts using existing genetic databases. Multiomic-based approaches and genome-wide association studies (GWAS) have been employed to uncover biological networks and common variants underlying host-pathogen interactions. Similarly, data derived from genomes, such as polygenic risk scores (PRS), ABO blood groups, and HLA haplotypes, can be potentially used to decipher COVID-19 complications, resistance, and susceptibility. Moreover, biobanks that link electronic health records (EHRs) to genomic data can be leveraged to study the impact of genomic factors on the clinical course of patients infected with SARS-CoV-2.   Gather more insights ...